In Vivo Pharmacodynamic Characterization of T-705 in an Experimental Influenza Infection Model in Mice

被引：0
作者：
Takahashi, K. [1 ]
Kadota, T. [1 ]
Tanaka, T. [1 ]
Komeno, T. [1 ]
Hayakawa, H. [1 ]
Mitsuyama, J. [1 ]
Furuta, Y. [2 ]
Shiraki, K. [3 ]
机构：
[1] Toyama Chem Co LTD, Res Labs, Toyama, Japan
[2] Toyama Chem Co LTD, Business Dev Dept, Tokyo, Japan
[3] Toyama Univ, Dept Virol, Toyama 930, Japan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.425
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E170 / E171
页数：2
相关论文
共 50 条
  • [31] Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
    Smither, Sophie J.
    Eastaugh, Lin S.
    Steward, Jackie A.
    Nelson, Michelle
    Lenk, Robert P.
    Lever, Mark S.
    ANTIVIRAL RESEARCH, 2014, 104 : 153 - 155
  • [32] Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs
    Rahim, Md N.
    Zhang, Zirui
    He, Shihua
    Zhu, Wenjun
    Banadyga, Logan
    Safronetz, David
    Qiu, Xiangguo
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S649 - S657
  • [33] T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
    Baranovich, Tatiana
    Wong, Sook-San
    Armstrong, Jianling
    Marjuki, Henju
    Webby, Richard J.
    Webster, Robert G.
    Govorkova, Elena A.
    JOURNAL OF VIROLOGY, 2013, 87 (07) : 3741 - 3751
  • [34] Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model
    Zhu, Wenjun
    Zhang, Zirui
    He, Shihua
    Wong, Gary
    Banadyga, Logan
    Qiu, Xiangguo
    ANTIVIRAL RESEARCH, 2018, 151 : 39 - 49
  • [35] Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever
    Gowen, Brian B.
    Sefing, Eric J.
    Westover, Jonna B.
    Smee, Donald F.
    Hagloch, Joseph
    Furuta, Yousuke
    Hall, Jeffery O.
    ANTIVIRAL RESEARCH, 2015, 121 : 132 - 137
  • [36] Growth activation of influenza virus by trypsin and effect of T-705 (favipiravir) on trypsin-optimized growth condition
    Daikokui, T.
    Okuda, T.
    Kawai, M.
    Morita, N.
    Tanaka, T.
    Takemoto, M.
    Fukuda, Y.
    Takahashi, K.
    Nomura, N.
    ShirakI, K.
    ACTA VIROLOGICA, 2019, 63 (03) : 309 - 315
  • [37] Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
    Morrey, John D.
    Taro, Brandon S.
    Siddharthan, Venkatraman
    Wang, Hong
    Smee, Donald F.
    Christensen, Andrew J.
    Furuta, Yousuke
    ANTIVIRAL RESEARCH, 2008, 80 (03) : 377 - 379
  • [38] Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) Analogues
    Wang, Guangyi
    Wan, Jingiao
    Hu, Yujian
    Wu, Xiangyang
    Prhavc, Marija
    Dyatkina, Natalia
    Rajwanshi, Vivek K.
    Smith, David B.
    Jekle, Andreas
    Kinkade, April
    Symons, Julian A.
    Jin, Zhinan
    Deval, Jerome
    Zhang, Qjngling
    Tam, Yuen
    Chanda, Sushmita
    Blatt, Lawrence
    Beigelman, Leonid
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4611 - 4624
  • [39] Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques
    Hawman, David W.
    Haddock, Elaine
    Meade-White, Kimberly
    Nardone, Glenn
    Feldmann, Friederike
    Hanley, Patrick W.
    Lovaglio, Jamie
    Scott, Dana
    Komeno, Takashi
    Nakajima, Nozomi
    Furuta, Yousuke
    Gowen, Brian B.
    Feldmann, Heinz
    ANTIVIRAL RESEARCH, 2020, 181
  • [40] In Vitro and In Vivo Efficacy of Combinational Therapy with Favipiravir (T-705) and Oseltamivir Against Influenza A/CA/04/09 Pandemic H1N1 Virus
    Barnard, Dale
    Furuta, Yousuke
    Klummp, Klaus
    Smee, Donald
    Morrey, John
    Tarbet, Bart
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A26 - A26
12345